Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Starling Continuous Renal Replacement Therapy (CRRT) Observational Study

NCT05729048 is registered in ClinicalTrials.gov with Baxter Healthcare Corporation as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05729048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Starling Continuous Renal Replacement Therapy (CRRT) Observational Study
Lead sponsor
Baxter Healthcare Corporation
Phase
Observational
Overall status
Withdrawn
Start date
July 15, 2023
Completion date
March 14, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodynamic monitoring